Report Highlights
The global market for smart inhalers should grow from $156.1 million in 2019 to $512.1 million by 2024 with a compound annual growth rate (CAGR) of 26.8% for the period of 2019-2024.
Report Includes
- 18 data tables and 14 additional tables
- Descriptive overview of the global smart inhalers market
- Analyses of the global market trends, with data corresponding to market size for 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Country specific data and analysis for the United States, Canada, Germany, France, Italy, Spain, UK, China, Japan, India and other emerging economies
- Latest information on market potential for smart inhalers, opportunities and restraints, technological advancements, regulatory scenario, and other macroeconomic trends affecting the marketplace
- Key merger and acquisition deals, partnerships, agreements, collaborations and joint ventures in global smart inhalers market
- Estimation of market size and forecast, and market share analysis of smart inhalers based on the product, disease indication, and geographical region
- A brief outline on the impact of COVID-19 pandemic on global smart inhalers market and MedTech
- Detailed profiles of the major listed pharmaceutical companies, including AstraZeneca plc, Boehringer Ingelheim Gmbh, GlaxoSmithKline Plc, Novartis AG , and Teva Pharmaceutical Industries Ltd.
Report Scope
The current report offers a comprehensive picture of the smart inhalers market. Smart inhalers prescribed for the treatment of asthma and COPD are included in the scope of the study. The report excludes the revenue of inhalers and sensors that operate independently. The focus of this report is instead the combined product, which consists of an inhaler and sensor and is called a smart inhaler; this is tracked and included in the report's current scope. The market size includes the revenue the smart inhaler generated for pharma companies. Digital companies merely provide the sensors to pharma companies; and pharma companies are the ones assembling smart inhalers and making them available.
The report explains the current and future market potential of smart inhalers. It offers a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints and market trends. The report covers market forecasts through 2024.
The report details market shares of smart inhalers based on product, disease indication and geography. Based on product, the market is fragmented into dry powder inhaler (DPI)-based smart inhalers and metered-dose inhaler (MDI)-based smart inhalers.
By disease indication, the market is segmented into asthma and COPD.
By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for the year 2018 as the base year, 2019 and forecast through year-end 2024. Estimated values used are based on pharma manufacturers’ total revenues and estimated installations of smart inhalers. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Anesthesia and Respiratory Devices: Global Markets (HLC167E)
- Global Quantum Batteries Market (FCB074A)
- Chromatography in Pharmaceuticals and Biotechnology: Global Markets (BIO163B)
- Global MedTech Healthcare IT Industry Competitive Landscape (MDS068B)
- Therapies for Rheumatoid Arthritis: Technologies and Global Markets (PHM072B)
Related Reports
Anesthesia and Respiratory Devices: Global Markets
The global market for anesthesia and respiratory devices is expected to grow from $51.9 billion in 2025 and is projected to reach $74.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2025 to 2030.
Needle-Free Devices: Technologies and Global Markets
The global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 through 2030.
Pulmonary Drug Delivery Systems: Technologies and Global Markets
The global pulmonary drug delivery systems market should reach $76.9 billion by 2027 from $57.4 billion in 2022 at a compound annual growth rate (CAGR) of 6.0% for the forecast period of 2022 to 2027.
Nebulizers, Inhalers and Respirators for Asthma Treatment: Global Markets
The global market for nebulizers, inhalers and respirators has reached nearly $11.2 billion and $12.4 billion in 2013 and 2014, respectively. This market is expected to grow at compound annual growth rate (CAGR) of 8.9% to reach $19.0 billion in 2019.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global MedTech Healthcare IT Industry Competitive Landscape
This report provides an overview of the global market landscape for medical technology (MedTech) healthcare IT industry. It includes the medical device industry, in vitro diagnostics (IVD) and the healthcare IT industry. The report covers key players, competitive intelligence, advanced technologies and company profiles. The analysis includes recent developments and product portfolios of major players, as well as market share analysis and ranking.
Global Mammography Equipment Markets
The global market for mammography equipment is projected to grow from $3.1 billion in 2025 to reach $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.
Smart Medical Devices: Global Markets
The global market for smart medical devices is projected to grow from $87.7 billion in 2025 to reach $193.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of 17.1% from 2025 through 2030.
Oncology Diagnostics: Global Markets
The global market for oncology diagnostics is estimated to increase from $77.6 billion in 2024 to reach $101.5 billion by 2029, at a compound annual growth rate (CAGR) of 5.5% from 2024 through 2029.
Colonoscopes: Global Markets
This report provides an overview of the global colonoscope market and analyzes market trends. It includes global revenue ($ millions) for the base year data of 2024, estimates for 2025, and projections of CAGRs throughout the forecast period, i.e., 2025 to 2030. The report concludes with a competitive landscape and profiles of the key market players.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More